Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Pacira Pharm Inc (PCRX)

34.5 -0.8 (-2.27%)

04-25 16:00

Open:

35.45

Pre. Close:

35.3

High:

36.35

Low:

32.555

Volume:

1,273,759

Market Cap:

1405M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

36.19 - 36.485

36.485 - 36.682

Low:

31.996 - 32.296

32.296 - 32.497

Close:

33.069 - 33.543

33.543 - 33.862

Technical analysis  (as of: 2018-04-25 4:29:58 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 44.85     One year: 52.39

Support:

Support1: 31.32    Support2: 26.95

Resistance:

Resistance1: 38.40    Resistance2: 44.85

Pivot:

34.69

Moving Averages:

MA(5): 35.13     MA(20): 33.34

MA(100): 37.08     MA(250): 39.61

MACD:

MACD(12,26): 0.81     Signal(12,26,9): 0.73

%K %D:

%K(14,3): 65.13     %D(3): 71.84

RSI:

RSI(14): 48.97

52-Week:

High: 52.48  Low: 26.95  Change(%): -30.3

Average Vol(K):

3-Month: 124192  10-Days 88535

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
PCRX has closed above bottom band by 32.1%. Bollinger Bands are 0.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-06T15:35:46-04:00
Pacira Pharma up 14% on (possible) FDA OK for Exparel

2018-04-02T10:35:18-04:00
Biotech Forum: The Week Ahead

2018-03-27T04:06:39-04:00
NHF: Objects In The Rear View Mirror Miss The Storms Ahead?

2018-03-21T07:53:34-04:00
Premarket analyst action - healthcare

2018-03-01T08:00:00-05:00
Your Daily Pharma Scoop: Celgene Setback, Valeant Results, Synergy Sells Rights

2018-02-28T14:30:55-05:00
Pacira Pharmaceuticals (PCRX) Q4 2017 Results - Earnings Call Transcript

2018-02-28T08:01:37-05:00
Pacira Pharmaceuticals beats by $0.28, misses on revenue

2018-02-27T17:30:22-05:00
Notable earnings before Wednesday's open

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

40.71

Shares Float (M)

40.36

% Held by Insiders

0.90

% Held by Institutions

Shares Short (K)

4922

Shares Short Prior Month (K)

5220

Stock Financials

EPS

-0.600

EPS Est. Current Year

-0.200

EPS Est. Next Year

0.910

EPS Est. Next Quarter

0.110

Forward EPS

1.060

Book Value (p.s.)

5.160

PEG Ratio

2.64

Profit Margin

-10.46

Operating Margin

-6.80

Return on Assets (ttm)

-8.4

Return on Equity (ttm)

-17.1

Qtrly Rev. Growth

8.5

Gross Profit (p.s.)

3.462

Sales Per Share

EBITDA (p.s.)

-0.671

Qtrly Earnings Growth

Operating Cash Flow (M)

17.79

Levered Free Cash Flow (M)

16.16

atoplab.com

Valuation

P/E

-55.79

P/E Growth Ratio

-0.05

P/BV

6.49

P/S

189273216.00

P/CF

76.61

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.